Karl A. Nath, MBChB, Editor-in-Chief of Mayo Clinic Proceedings, discusses the Editor’s Choice and Highlights articles appearing in the September 2022 issue.
“Association of Self-Reported Walking Pace With Type 2 Diabetes Incidence in the UK Biobank Prospective Cohort Study,” by Dr Jirapitcha Boonpor and colleagues;
“Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement,” by Dr Sunil K. Sahai and colleagues; and
“Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease-2019,” by Dr Raymund R. Razonable and colleagues.
Supplemental Online Material